CONSIGLIO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.503
EU - Europa 1.075
AS - Asia 478
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
SA - Sud America 2
Totale 4.066
Nazione #
US - Stati Uniti d'America 2.498
CN - Cina 369
PL - Polonia 352
UA - Ucraina 285
DE - Germania 125
IT - Italia 82
HK - Hong Kong 75
GB - Regno Unito 69
FI - Finlandia 57
IE - Irlanda 50
FR - Francia 17
VN - Vietnam 16
ES - Italia 15
BE - Belgio 14
IN - India 5
RU - Federazione Russa 5
CA - Canada 4
IR - Iran 4
EU - Europa 3
SD - Sudan 3
SG - Singapore 3
TR - Turchia 3
AU - Australia 2
SA - Arabia Saudita 2
SE - Svezia 2
BO - Bolivia 1
BR - Brasile 1
EE - Estonia 1
MX - Messico 1
NO - Norvegia 1
TH - Thailandia 1
Totale 4.066
Città #
Fairfield 436
Woodbridge 376
Warsaw 352
Jacksonville 210
Houston 194
Ashburn 178
Cambridge 167
Seattle 153
Ann Arbor 145
Wilmington 143
Princeton 99
Hong Kong 74
Nanjing 72
Dearborn 69
Chandler 67
Brescia 56
Beijing 52
Dublin 50
Changsha 29
Hebei 26
Nanchang 26
New York 26
Helsinki 25
Jinan 25
Des Moines 23
Shenyang 21
San Francisco 20
Dong Ket 16
San Diego 16
Tianjin 15
Brussels 14
Barcelona 13
Jiaxing 12
Kunming 11
Ningbo 11
Zhengzhou 11
London 10
Hangzhou 9
Hefei 8
Milan 8
Changchun 6
Haikou 5
Leawood 5
San Mateo 5
Taiyuan 5
Taizhou 5
Augusta 4
Boardman 4
Lanzhou 4
West Jordan 4
Ardabil 3
Chiswick 3
Fuzhou 3
Kilburn 3
Lancaster 3
Prescot 3
Shanghai 3
St Louis 3
Verona 3
Castenedolo 2
Guangzhou 2
Hounslow 2
Norwalk 2
Phoenix 2
Riyadh 2
Toronto 2
Travagliato 2
Wandsworth 2
Bangalore 1
Bessbrook 1
Canberra 1
Central 1
Chicago 1
Falkenstein 1
Frankfurt am Main 1
Guadalupe 1
Lecce 1
Markham 1
Melbourne 1
Monmouth Junction 1
Montreal 1
New Bedfont 1
Nuoro 1
Nürnberg 1
Orange 1
Oslo 1
Padova 1
Rende 1
Rome 1
Sabz 1
Songkhla 1
Southwark 1
Sucre 1
Tallinn 1
Tower Hamlets 1
Vieste 1
Wenzhou 1
Wuhan 1
Yellow Springs 1
Totale 3.391
Nome #
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 219
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. 208
Clinical potentials of human pluripotent stem cells 195
Synapse formation on neurons born in the adult hippocampus 170
In vivo demonstration that alpha-synuclein oligomers are toxic. 144
ER signaling regulation drives the switch between autophagy and apoptosis in NRK-52E cells exposed to cisplatin 122
Using iPS cells toward the understanding of parkinson'€™s disease 114
Activity and high-order effective connectivity alterations in sanfilippo C patient-specific neuronal networks 107
Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts. 99
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises 99
The zebrafish as a model of heart regeneration 97
A new generation stable inducible packaging cell line for lentiviral vectors. 95
Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. 94
Interplay of LRRK2 with chaperone-mediated autophagy. 94
Generation of cardiomyocytes from new human embryonic stem cell lines derived from poor-quality blastocysts. 93
Wnt signalling regulates adult hippocampal neurogenesis 90
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. 90
MT5-MMP regulates adult neural stem cell functional quiescence through the cleavage of N-cadherin. 90
Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients 90
A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. 89
Dentate gyrus-specific knockdown of adult neurogenesis impairs spatial and object recognition memory in adult rats. 89
Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1. 88
Derivation of human embryonic stem cells at the Center of Regenerative Medicine in Barcelona. 88
Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. 88
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. 86
In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus 86
Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency. 83
Signaling through BMPR-IA regulates quiescence and long-term activity of neural stem cells in the adult hippocampus. 80
TThe Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity 79
Improved conditions for the analysis of large variable number of tandemly repeated (VNTR) unit polymorphisms. 78
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 76
Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells 75
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. 73
Tumor necrosis factor and its receptors (R1 and R2) in relapsing-remitting multiple sclerosis. 71
In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice 68
iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology 66
Expression and purification of a human soluble Arylsulfatase A for MLD enzyme replacement therapy 55
Cyclin a(1) is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells. 48
Proinflammatory cytokines regulate antigen-indipendent T- cell activation by two separate calcium- signalling pathways in multiple sclerosis patients. 43
Occurence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. 42
MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients 40
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration 27
Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease 25
CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons 23
Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases 23
Global Proteomic and Methylome Analysis in Human Induced Pluripotent Stem Cells Reveals Overexpression of a Human TLR3 Affecting Proper Innate Immune Response Signaling 21
Stable and efficient genetic modification of cells in the adult mouse V-SVZ for the analysis of neural stem cell autonomous and non-autonomous effects 18
Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson's disease patients 18
Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons 15
Successful gene therapy approach for a murine model of MLD. 13
Lentiviral vector for gene therapy of metachromatic leukodystrophy. 4
Dissecting the non-neuronal cell contribution to Parkinson's disease pathogenesis using induced pluripotent stem cells 3
SOX2 DEFINES NEURAL STEM CELL POPULATIONS IN THE ADULT BRAIN 3
Correction of neuropathology and behavioral deficits in ASA-deficient mice after lentiviral-mediated gene transfer into the brain 3
Wnt-signaling regulates adult brain neurogenesis. 3
Tetrahydrobiopterin (BH4) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock‐in mouse model 3
Restoration of normal lysosomal function in MLD oligodendrocytes through transduced C2C12 conditioned medium. 2
In Vitro cytotoxic activity of taxol on primary cultures of ovarian carcinoma cells from ascitic fluid of patients treated or non-treated with platin therapeutic compounds. 2
Synaptogenesis of new neurons in the adult hippocampus. 2
Adult neural stem cells as a tool for gene therapy of Tay-Sachs disease. 2
Correction of neuropathology and behavioral deficits in ASA-deficient mice after lentiviral-mediated gene transfer into the brain 2
iPSC‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation 2
Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite 1
Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson's disease 1
Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice 1
Lentiviral vector mediating fate mapping revealed the presence of long-term NSC in the adult brain. 1
Bone Marrow Transplantation And Gene Therapy For Metachromatic Leukodystrophy 1
Restoration of Arylsulphatase A activity in murine metachromatic leukodystrophy oligodendrocytes by retroviral vector-mediated gene transfer. 1
In vivo gene transfer in adult mammalian neural stem cells by lentiviral vector. 1
Long-term labeling of hippocampal neural stem cells by a lentiviral vector 1
Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons 1
Totale 4.124
Categoria #
all - tutte 19.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019232 0 0 0 0 0 0 0 0 0 0 132 100
2019/20201.385 147 44 49 148 85 170 135 149 100 226 60 72
2020/2021871 18 139 55 109 27 73 36 93 106 76 106 33
2021/2022418 50 59 6 13 3 28 15 22 18 48 30 126
2022/2023272 69 4 1 17 20 66 0 36 36 1 9 13
2023/2024238 31 4 36 6 18 26 13 10 87 6 1 0
Totale 4.124